Content Library

 Sample Attendee List

Neoantigen Europe Summit 2020

Join leading minds from companies that are pioneering this movement to help bring these emerging therapeutics to market

HW191105 Neoantigen Europe 2020 logo

Access past presentations from the NeoAg Event Series!

Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences

Beyond Algorithms:  the ATLAS Bioassay Method for Neoantigen Identification and Characterization


Andrew Allen, CEO,  Gritstone Oncology

Using Normal Immune Responses as Engine for Cancer Immunotherapy


Gavin MacBeath, Chief Scientific Officer, TScan Therapeutics

A Genome-wide Approach to Discovering Novel Targets and TCRs for T Cell Therapy


Hans-Peter Gerber ,CSO & SVP, 3T Biosciences

Identification of Novel Shared Targets in Solid Tumors